Abstract
A Leptomonas of insect origin was highly susceptible to several standard trypanocides and leishmanicides in vitro. Resistance was induced to some of these drugs; clones were isolated from each strain. Cross-resistance patterns of the clones were derived for diamidines, quinapyramine (Antrycide), acriflavin, phenanthridines, and other drugs active against trypanosomes and leishmanias. Clones tested included two each that were resistant to acriflavin, Antrycide, diminazene aceturate (Berenil), and pentamidine and one that was resistant to stilbamidine. Appreciable cross-resistance was evident for all clones. Differences were observed between clones from the same parent strain. Collateral susceptibility towards isometamidium and oxophenarsine was detected in most clone-derived populations. In clones passaged without drug to test for drug fastness, acriflavin and pentamidine clones lost resistance within 10 transfers, whereas Berenil and Antrycide clones retained considerable resistance after 20 to 30 subcultures without drug. Considerations of differences in life cycles suggest that the clone collection may be useful in screening for agents effective against leishmanias and stercorarian trypanosomes rather than against salivary trypanosomes.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- BULDER C. J. LETHALITY OF THE PETITE MUTATION IN PETITE NEGATIVE YEASTS. Antonie Van Leeuwenhoek. 1964;30:442–454. doi: 10.1007/BF02046758. [DOI] [PubMed] [Google Scholar]
- Bacchi J., Lambros C., Goldberg B., Hutner S. H., de Carvalho G. D. Susceptibility of an insect Leptomonas and Crithidia fasciculata to several established antitrypanosomatid agents. Antimicrob Agents Chemother. 1974 Dec;6(6):785–790. doi: 10.1128/aac.6.6.785. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Barrett-Connor E. Chemoprophylaxis of amebiasis and African trypanosomiasis. Ann Intern Med. 1972 Nov;77(5):797–805. doi: 10.7326/0003-4819-77-5-797. [DOI] [PubMed] [Google Scholar]
- Bray R. S. Leishmania. Annu Rev Microbiol. 1974;28(0):189–217. doi: 10.1146/annurev.mi.28.100174.001201. [DOI] [PubMed] [Google Scholar]
- Brener Z. Biology of Trypanosoma cruzi. Annu Rev Microbiol. 1973;27:347–382. doi: 10.1146/annurev.mi.27.100173.002023. [DOI] [PubMed] [Google Scholar]
- Brown R. C., Evans D. A., Vickerman K. Changes in oxidative metabolism and ultrastructure accompanying differentiation of the mitochondrion in Trypanosoma brucei. Int J Parasitol. 1973 Sep;3(5):691–704. doi: 10.1016/0020-7519(73)90095-7. [DOI] [PubMed] [Google Scholar]
- Howell N., Molloy P. L., Linnane A. W., Lukins H. B. Biogenesis of mitochondria 34. The synergistic interaction of nuclear and mitocohondrial mutations to produce resistance to high levels of mikamycin in Saccharomyces cerevisiae. Mol Gen Genet. 1974;128(1):43–54. doi: 10.1007/BF00267293. [DOI] [PubMed] [Google Scholar]
- Joyner L. P., Brocklesby D. W. Chemotherapy of anaplasmosis, babesiasis, and theileriasis. Adv Pharmacol Chemother. 1973;11:321–355. doi: 10.1016/s1054-3589(08)60461-5. [DOI] [PubMed] [Google Scholar]
- Rank G. H., Robertson A., Phillips K. Reduced plasma membrane permeability in a multiple cross-resistant strain of Saccharomyces cerevisiae. J Bacteriol. 1975 May;122(2):359–366. doi: 10.1128/jb.122.2.359-366.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Strauss P. R. Acriflavin resistance in the hemoflagellate, Leishmania tarentolae. J Cell Biol. 1972 May;53(2):312–334. doi: 10.1083/jcb.53.2.312. [DOI] [PMC free article] [PubMed] [Google Scholar]
- WILLIAMSON J. Chemotherapy and chemoprophylaxis of African trypanosomiasis. Exp Parasitol. 1962 Oct;12:323–367. doi: 10.1016/0014-4894(62)90046-2. [DOI] [PubMed] [Google Scholar]
- Walker P. J. Reproduction and heredity in trypanosomes. A critical review dealing mainly with the African species in the mammalian host. Int Rev Cytol. 1964;17:51–98. doi: 10.1016/s0074-7696(08)60405-2. [DOI] [PubMed] [Google Scholar]
- Williamson J., Scott-Finnigan T. J. Trypanocidal activity of antitumour antibodies and other metabolic inhibitors. Trans R Soc Trop Med Hyg. 1975;69(1):1–2. [PubMed] [Google Scholar]